ganglioside GM2 (natural compound)

Term ID

CHEBI:141420

Synonyms

(2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
(Neu5Ac)M2
beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
GalNacbeta1->-4(Neu5Acalpha2->3)Galbeta1->4Glcbeta-Cer
GalNacbeta1->-4(NeuAcalpha2->3)Galbeta1->4Glc-Cer

Definition

A naturally occurring mixture of ganglioside GM2 analogues having within the ceramide moiety various N-acyl groups, e.g. octadecanoyl (R = -[CH2]16CH3 in the diagram), icosanoyl (R = -[CH2]18CH3), tetracos-15-enoyl (R = -[CH2]13HC=CH[CH2]7CH3).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: mixture

mixture Show first 5 Terms
has_part: beta-D-GalpNAc-(1->4)-[alpha-Neup5Gc-(2->3)]-beta-D-Galp-(1->4)-R group ganglioside GM2 (18:0) ganglioside GM2 (20:0) ganglioside GM2 (24:1)

beta-D-GalpNAc-(1->4)-[alpha-Neup5Gc-(2->3)]-beta-D-Galp-(1->4)-R group ganglioside GM2 (18:0) ganglioside GM2 (20:0) ganglioside GM2 (24:1) Show first 5 Terms

Phenotype

Phenotype resulting from ganglioside GM2 (natural compound)

Phenotype where environments contain ganglioside GM2 (natural compound)

Phenotype modified by environments containing ganglioside GM2 (natural compound)

Human Disease Model